Loading decisions…
Loading decisions…
38,945 vetted Board decisions for Peripheral neuropathy.
The Veteran's claim for an effective date prior to January 21, 2021 for the grant of service connection for chronic ulnar mononeuropathy with carpal tunnel syndrome was denied.,The Veteran's appeal for an earlier effective date for TDIU prior to January 21, 2021 was also denied.
Service connection is granted for prostate cancer and hypertension associated with herbicide agent exposure under the PACT Act.,The Veteran's service in Korea from June 1968 to January 1969 was presumed due to his exposure to herbicide agents.
The Veteran's service connection claims for diabetes mellitus type II, left and right lower and upper extremity diabetic neuropathy, and bilateral cataracts are all granted. The claim for service connection for tension headaches is remanded.
The Board has denied the Veteran's claims for service connection for peripheral neuropathy in his upper and lower extremities, finding no evidence of a current disability or a causal link to service.
The Board has granted service connection for left and right upper extremity neuropathy, finding that the conditions are related to herbicide agent exposure in Vietnam.
The Board has remanded the Veteran's claims for service connection for peripheral neuropathy of all four extremities due to a lack of adequate medical opinion regarding his presumed exposure to herbicide agents during service.
The Veteran's migraine headaches are granted a higher rating of 50% from April 27, 2019 to October 21, 2019. Other conditions have been granted service connection with effective dates ranging from January 11, 2012 to October 21, 2019.
The Veteran's peripheral neuropathy of the left and right upper extremities, PTSD, left knee condition, and right knee condition are all granted service connection.,Service connection for COPD is remanded due to insufficient evidence.
The Veteran's claims for service connection for various conditions, including ED, bilateral hearing loss, and peripheral neuropathy in the upper and lower extremities, were denied. The Board found no evidence of a penile deformity or other qualifying condition to warrant a compensable rating for ED. For bilateral hearing loss, the Board determined that the Veteran did not meet the criteria for a greater than 10 percent rating from January 27, 2022 to April 9, 2022 and was denied a compensable rating thereafter.
The Veteran's type II diabetes mellitus and related peripheral neuropathies were granted increased ratings, while hypertension was also granted. Service connection for PVD was denied.
The Board has denied the Veteran's claims for service connection for bilateral upper and lower extremity peripheral neuropathies, including CIDP, due to Agent Orange exposure. The evidence does not support a finding that these conditions are related to service.
The Board has denied service connection for diabetes mellitus type II.,The Board has remanded the claims for rashes, LUE peripheral neuropathy, RUE peripheral neuropathy, LLE peripheral neuropathy, and RLE peripheral neuropathy secondary to herbicide exposure.
The Board has granted service connection for coronary artery disease, diabetes mellitus, and bilateral upper and lower extremity peripheral neuropathy due to herbicide exposure. The conditions are presumed based on the Veteran's in-service travel to Vietnam.
The Veteran's claim for a compensable disability rating for traumatic amputation of the right second and third toes was denied. Effective dates of August 31, 2012 were granted for service connection of right foot scars and right foot neuropathy.
The Veteran's claim for attorney fees based on past-due benefits awarded in an August 2021 rating decision was dismissed as the appellant no longer wished to pursue the appeal.
The Veteran's appeals for service connection on the issues of coronary artery disease, Type 2 diabetes mellitus, chronic kidney disease as secondary to Type 2 diabetes mellitus, diabetic peripheral neuropathy of the right lower extremity as secondary to Type 2 diabetes mellitus, and diabetic peripheral neuropathy of the left lower extremity have been dismissed due to the Veteran's withdrawal prior to the Board's decision.
The Veteran's service-connected disabilities (PTSD, diabetes, peripheral neuropathy, and tinnitus) render him unable to secure or follow a substantially gainful occupation consistent with his education and work history.
The Veteran's service-connected disabilities rendered him unable to obtain and maintain substantially gainful employment since April 8, 2017. The effective date for the grant of TDIU is set at April 8, 2017.
The Board denied the Veteran's claims for service connection for diabetes mellitus type II and peripheral neuropathy of the bilateral lower extremities due to lack of evidence of herbicide agent exposure during his active duty service.
The Veteran's claims for increased ratings for various conditions are being remanded due to a failure to obtain Social Security Administration (SSA) records.
← Back to Peripheral neuropathy overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.